Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reinventing HCV Treatment: Past and Future Perspectives.

Literature DB >> 27654843

Reinventing HCV Treatment: Past and Future Perspectives.

Wendy Carter¹, Sarah Connelly¹, Kimberly Struble¹.

Abstract

This review paper summarizes the epidemiology of hepatitis C virus (HCV) and chronic HCV infection, including HCV virology and treatment regimens. Specifically, we focus on the evolution of past, current, and future HCV treatment options, the reasons for treatment failure, and the impact of resistance-associated variants on treatment success.

Entities: Chemical

Keywords: direct-acting antivirals; genotype; hepatitis C; resistance-associated variants; sustained virologic response

Mesh：

Substances：

Year: 2016 PMID： 27654843 DOI： 10.1002/jcph.830

Source DB: PubMed Journal: J Clin Pharmacol ISSN： 0091-2700 Impact factor: 3.126

Keyword Cloud
Cited

12 in total

Review 1. Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use.

Authors: Sabrina Bagaglio; Caterina Uberti-Foppa; Giulia Morsica
Journal: Drugs Date: 2017-07 Impact factor: 9.546

Review 2. Functional RNA structures throughout the Hepatitis C Virus genome.

Authors: Rebecca L Adams; Nathan Pirakitikulr; Anna Marie Pyle
Journal: Curr Opin Virol Date: 2017-05-13 Impact factor: 7.090

3. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.

Authors: Meredith S Shiels; Eric A Engels; Elizabeth L Yanik; Katherine A McGlynn; Ruth M Pfeiffer; Thomas R O'Brien
Journal: Cancer Date: 2019-04-12 Impact factor: 6.921

Review 4. The 5BSL3.2 Functional RNA Domain Connects Distant Regions in the Hepatitis C Virus Genome.

Authors: Cristina Romero-López; Alfredo Berzal-Herranz
Journal: Front Microbiol Date: 2017-10-31 Impact factor: 5.640

5. The design and statistical aspects of VIETNARMS: a strategic post-licensing trial of multiple oral direct-acting antiviral hepatitis C treatment strategies in Vietnam.

Authors: Leanne McCabe; Ian R White; Nguyen Van Vinh Chau; Eleanor Barnes; Sarah L Pett; Graham S Cooke; A Sarah Walker
Journal: Trials Date: 2020-05-18 Impact factor: 2.279

6. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China.

Authors: Ying Yang; Feng-Ping Wu; Wen-Jun Wang; Juan-Juan Shi; Ya-Ping Li; Xin Zhang; Shuang-Suo Dang
Journal: World J Gastroenterol Date: 2019-11-28 Impact factor: 5.742

Reinventing HCV Treatment: Past and Future Perspectives.

Review 1. Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use.

Review 2. Functional RNA structures throughout the Hepatitis C Virus genome.

3. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.

Review 4. The 5BSL3.2 Functional RNA Domain Connects Distant Regions in the Hepatitis C Virus Genome.

5. The design and statistical aspects of VIETNARMS: a strategic post-licensing trial of multiple oral direct-acting antiviral hepatitis C treatment strategies in Vietnam.

6. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China.

Review 7. Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C.

Review 8. Ledipasvir/Sofosbuvir: A Review in Chronic Hepatitis C.

9. Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis.

Review 10. The Role of PD-1 in Acute and Chronic Infection.